Patents by Inventor CAROL Dian MARTIN
CAROL Dian MARTIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210085870Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: ApplicationFiled: November 20, 2020Publication date: March 25, 2021Applicant: MONARCH MEDICAL TECHNOLOGIES, LLCInventors: TIMOTHY L. RUCHTI, WILLIAM PATRICK BURGESS, JOHN DUMAS, III, RONALD LISIECKI, CAROL DIAN MARTIN, LAURA SANTANA, JOHN HARRISON THORNLEY, JOANNE MARIE WATT
-
Patent number: 10842935Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: GrantFiled: July 30, 2018Date of Patent: November 24, 2020Assignee: Monarch Medical Technologies, LLCInventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
-
Publication number: 20180333535Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: ApplicationFiled: July 30, 2018Publication date: November 22, 2018Applicant: Monarch Medical Technologies, LLCInventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
-
Patent number: 10046113Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: GrantFiled: December 21, 2012Date of Patent: August 14, 2018Assignee: Monarch Medical Technologies, LLCInventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
-
Publication number: 20170165425Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.Type: ApplicationFiled: December 21, 2012Publication date: June 15, 2017Applicant: EndoTool, LLCInventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
-
Patent number: 8771251Abstract: In example methods and systems described, a medical device can store information locally and in a separate database on a server, for example. If the device fails, or a patient is moved to a second device, information may be transferred to the second device such that the second device can resume a complex therapy at a point where the initial medical device left off. The data necessary to restart the complex therapy system may include certain underlying patient-specific parameters according to a model capturing the patient's physiological response to the medication in question. As a result, it is not necessary for the second device to restart the complex therapy or regress to an initial set of baseline assumptions.Type: GrantFiled: December 16, 2010Date of Patent: July 8, 2014Assignee: Hospira, Inc.Inventors: Timothy Lewis Ruchti, Steven R. Wehba, John Harrison Thornley, Harsh Dharwad, Joanne Marie Watt, Carol Dian Martin, Suzanne Willey
-
Publication number: 20110152830Abstract: In example methods and systems described, a medical device can store information locally and in a separate database on a server, for example. If the device fails, or a patient is moved to a second device, information may be transferred to the second device such that the second device can resume a complex therapy at a point where the initial medical device left off. The data necessary to restart the complex therapy system may include certain underlying patient-specific parameters according to a model capturing the patient's physiological response to the medication in question. As a result, it is not necessary for the second device to restart the complex therapy or regress to an initial set of baseline assumptions.Type: ApplicationFiled: December 16, 2010Publication date: June 23, 2011Applicant: HOSPIRA, INC.Inventors: TIMOTHY L. RUCHTI, STEVEN R. WEHBA, JOHN Harrison THORNLEY, HARSH DHARWAD, JOANNE Marie WATT, CAROL Dian MARTIN, SUZANNE WILLEY